According to documents submitted to the SEC, biotechnology company Avai Bio Inc and Ainnova Tech have agreed, as of May 7, 2026, to jointly terminate their previously established joint venture and related licensing agreements.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Deputy Governor of the Reserve Bank of Australia warns of “significantly worsening” inflation outlook; probability of rate hike in November rises to 43%
Hauser stated on Wednesday that Australia’s inflation outlook appears “significantly worse” than the Reserve Bank of Australia’s forecast in August, mainly due to rising oil and technology product prices, as well as persistent domestic pressures.
Jim Cramer Prefers Gold to Bitcoin for Portfolio Insurance, but Backs 2 ‘Vetted’ Cryptos
"Burry the Big Short": Court ruling and the 2027-28 ownership review are 'good news' for Fannie Mae and Freddie Mac
"The Big Short" investor Michael Burry stated on Tuesday that the recent court victory by shareholders of Fannie Mae and Freddie Mac, along with U.S. Treasury Secretary Scott Bessent's remarks on ultimately resolving the ownership structures of these two companies, constitutes "good news" for them.
Korean Stocks Rise Over 3%, SK Hynix and Samsung Electronics Up About 6%
Crypto prices
More
